Gene Query: ATG13

Dataset Description Geneva Score
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 49.07
Gene expression analysis of dengue-infected cells 47.46
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 40.77
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 37.12
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 25.33
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 21.52
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 21.52
Differential analysis of HOXA1 in adult cells at isoform resolution by RNA-Seq [Illumina] 20.8
Differential analysis of gene regulation at transcript resolution by RNA-Seq 20.8
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 20.23
MYCi361 regulates MYC target genes 19.11
Gene expression in PANC1 cells treated with Rakicidin 18.58
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 18.32
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 17.49
Gene expression changes upon drug withdrawal (Mel888 cell line) 16.55
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 16.48
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 16.04
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 16.04
A TGFbeta-PRMT5-MEP50 Axis Regulates Cancer Cell Invasion through Histone H3 and H4 Arginine Methylation Coupled Transcriptional Activation and Repression 15.95
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 15.86
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 15.86
Gene expression profile of human multiple myeloma cell line MM.1S after knockdown of KDM6B 15.63
Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function 15.6
SUV420H2 knockdown in PANC-1 14.89
Systems-level analyses reveal a convergent pathway for progression of diffuse astrocytoma and potential role for resveratrol in delaying high-grade transformation 14.57
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 14.26
Pharmacologic inhibition of STAT5 in AML 13.85
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 13.72
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 13.68
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 13.33
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 13.33
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 13.24
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 13.19
Silencing SPIB in attached and floating state of H1703 lung cancer cells 12.96
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 12.67
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 12.51
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 12.45
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 12.08
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 11.86
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 11.86
An integrative analysis of non-coding regulatory DNA variations associated with autism 11.82
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 11.7
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 11.7
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 11.62
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 11.59
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 11.52
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 11.5
Genome-wide analysis of Dengue virus 2 infected cells 11.4
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 11.29
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 11.29
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 11.22
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 11.02
Expression profiling of MCF-7 cells with treatment of TCDD 11.02
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 10.98
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 10.83
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 10.83
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 10.77
RNA-seq analysis to identify the genes regulated by p53-SET interplay 10.73
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 10.68
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 10.49
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 10.33
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 10.23
Genome wide expression change by RNF168 knocking down in MCF-7 cells 10.16
MicroRNA-125a-5p overexpression in human macrophages 10.1
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 10.0
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 9.87
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 9.69
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 9.67
Low-Cell-Number, Single-Tube Amplification (STA) of RNAs Revealed miRNA Changes from Pluripotency to Endothelium 9.67
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 9.66
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 9.37
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 9.32
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 9.32
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 9.27
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 9.27
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 9.08
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 8.99
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 8.85
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 8.8
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 8.72
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 8.64
RIG-I and MDA5 fRIP during KSHV lytic reactivation 8.62
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 8.37
RNA-Seq from early time points in the kidney differentiation protocol 8.36
The landscape of alternative splicing in aggressive prostate cancers 8.33
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 8.22
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 8.21
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 8.17
Total RNA sequencing of WT intestinal orgaonids. 8.13
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 8.12
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 8.11
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 8.09
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 8.09
RNA Seq of HMVEC under hypoxia 8.08
Endothelial-AGO1-knockout (EC-AGO1-KO) mice and wild-type (WT) littermates 8.08
Identification of the role of polydom in neurofibromas 8.06
EWSR1 influences alternative splicing through direct and indirect mechanisms 7.93
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 7.9
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 7.8
mRNA expression in human DAOY cells 7.79
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 7.77
ETV7 and interferon response 7.77
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 7.75
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 7.75
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 7.74
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 7.7
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 7.64
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 7.63
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 7.6
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 7.57
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 7.57
mRNA expression profile of Lymphocytes by high-throuput sequencing 7.53
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 7.53
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 7.49
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 7.44
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 7.44
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 7.43
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 7.39
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 7.39
Unique features and clinical importance of acute alloreactive immune responses 7.37
RNA expression following TMPRSS11B overexpression or depletion 7.37
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 7.27
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 7.23
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 7.22
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 7.19
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 7.15
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 7.15
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 7.08
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 7.0
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 7.0
LncRNA-GAS5 negative regulation of YAP-target genes expression 6.99
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 6.85
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 6.81
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 6.79
RNA-seq in transgenic cells 6.78
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 6.74
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 6.69
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 6.68
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 6.66
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 6.66
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 6.65
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 6.57
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 6.54
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 6.54
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 6.54
The regulartory role of ZCCHC24 in splicing machinery 6.47
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 6.44
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 6.4
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 6.38
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 6.34
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 6.33
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 6.26
Developmental stage specific chromosome architecture in human erythroid cells 6.26
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 6.26
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 6.25
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 6.21
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 6.19
Mechanistic Model-Guided Study of Embryonic Morphogenesis 6.18
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 6.14
RNAseq Study in CC-671 Treated Cal-51 Cells 6.13
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 6.12
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 6.12
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 6.09
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 6.09
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 6.09
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 6.07
Biological effect of chronic mistranslation in mammalian cells 6.07
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 6.03
Gene expression changes caused by KRAS in MCF-10A 5.98
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 5.98
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 5.98
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 5.95
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 5.94
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 5.94
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 5.93
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 5.91
circRNA-sequencing 5.91
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 5.89
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 5.86
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 5.86
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 5.85
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 5.84
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 5.82
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 5.78
Genome-wide analysis of ferroptosis related genes in liver cancer cells. 5.76
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 5.75
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 5.74
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 5.74
IDH3a KO RNA-seq 5.73
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 5.71
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4+CD25+ T regulatory cells activation 5.71
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 5.66
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 5.62
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 5.61
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 5.6
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 5.56
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 5.56
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 5.56
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 5.55
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 5.55
Effect of Toxoplasma gondii efector TgIST on global transcriptome of human foreskin fibroblasts (HFFs) upon type I IFN activation 5.55
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 5.54
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 5.54
RNA-sequencing in immortalized human mammary epithelial cells 5.51
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 5.51
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 5.49
Gene expression analysis of immortalized human liver progenitor-like cells in culture 5.49
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 5.48
Hepatitis C virus functionally sequesters miR-122 5.48
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 5.48
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 5.45
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 5.44
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 5.43
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 5.41
Regulation of hypoxia-inducible factor activity by ZMYND8 5.37
Genome-wide analysis of the Integrator complex 5.36
Genome-wide analysis of the Integrator complex (HTS) 5.36
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 5.34
3’ Uridylation Expands miRNA Target Repertoire 5.32
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 5.3
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 5.28
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 5.24
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 5.24
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 5.24
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 5.22
Identification of Sin3B regulated genes during quiescence 5.22
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 5.19
Genome-wide chromatin analysis of Ewing sarcoma 5.19
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 5.1
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 5.09
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 5.09
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 5.07
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 4.98
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 4.91
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 4.91
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 4.84
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 4.84
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 4.81
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 4.8
RNA-seq differential expression studies: more sequence, or more replication? 4.79
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 4.78
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 4.74
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 4.72
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 4.71
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 4.66
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 4.63
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 4.59
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 4.59
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 4.56
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 4.49
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 4.47
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 4.47
Searching for target genes of miR-508/509/506/514 in HCT116 cells 4.47
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 4.46
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 4.46
Interaction between mitoNEET and NAF-1 in cancer cells 4.44
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 4.43
Identification of HOXB13 target genes responsive to BET inhibitors 4.43
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 4.38
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 4.38
Effect of BB608 on Gene Expression in HNSCC Cell Line 4.37
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 4.36
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 4.34
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 4.32
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 4.32
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 4.32
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 4.31
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 4.29
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 4.29
Gene expression profiling of KSHV-infected periodontal ligament cells 4.29
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 4.28
Toxoplasma gondii infection of human retinal pigment epithelial cells 4.26
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 4.19
Regulating Interleukin-2 activity with engineered receptor signaling clamps 4.18
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 4.14
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 4.14
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 4.09
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 4.09
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 4.08
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 4.06
MARS Seq data from human cortical organoids 4.03
Expression by CD133+ cells isolated from the adult human exocrine pancreas 3.98
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 3.91
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 3.87
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 3.86
Effect of from Human Umbilical Vein Endothelial Cells 3.81
Gene expression signatures of innate lymphoid cells from human blood 3.78
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 3.77
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.75
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 3.75
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 3.74
3.73
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 3.7
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 3.7
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 3.66
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 3.66
RNA-seq analysis of differentiating human erythroblasts 3.65
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 3.63
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 3.63
Stem and effector CD8 T-cells from human cancers 3.62
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 3.6
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 3.6
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 3.58
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 3.56
RNA seq comparison between scrambled and shGRP78 cells 3.55
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 3.54
In situ CAPTURE of chromatin interactions by biotinylated dCas9 3.53
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 3.53
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 3.53
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 3.52
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.5
RNA-seq of IL-4 stimulated human keratinocytes 3.48
Transcriptome of activated human and mouse MAIT cells 3.35
Illumina Total RNA-seq in HeLa 3.3
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 3.29
X-Ray induced DNA-Hydroxymethylation changes 3.26
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 3.24
RNA-seq of RKO cells with cTAZ KO or putback 3.24
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 3.23
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 3.18
Integration of genome-wide DNA methylome and transcriptome of human intestinal fibroblasts reveals novel candidate gene signatures in Crohn’s disease-associated fibrosis 3.12
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 3.12
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 3.05
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 3.05
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 3.04
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 3.01
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 3.0
Human HAP1 cells before and after nutrient deprivation 3.0
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 2.97
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 2.93
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 2.93
ARS2 is a general suppressor of pervasive transcription [RNAseq] 2.91
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 2.89
Effect of PBK knockdown on C4-2 cell transcriptome 2.74
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 2.73
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 2.7
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.7
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.7
Comparative Analysis of Cas9 Activators Across Multiple Species 2.64
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.63
The RNA-binding protein RBM47 suppresses metastatic breast cancer progression 2.62
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 2.57
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 2.51
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 2.47
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 2.44
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 2.44
Downregulation of DDX5/DDX17 and REST 2.44
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 2.43
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 2.36
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.36
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 2.35
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 2.33
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 2.3
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 2.28
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 2.28
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 2.23
Identification of global XBP1s target gene expression in human prostate cancer cells 2.2
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.2
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  2.19
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 2.19
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 2.19
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 2.09
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 2.09
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 2.09
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 2.08
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 2.07
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 2.04
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 1.96
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 1.96
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 1.96
RNA editing in nascent RNA affects pre-mRNA splicing 1.95
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 1.93
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 1.92
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 1.9
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 1.9
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 1.89
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 1.89
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 1.88
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 1.88
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 1.86
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 1.83
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.76
H1609088 Human RNA-Sequencing 1.76
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 1.75
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 1.73
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 1.73
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.71
Effect of nuclear IL-33 on gene expression 1.69
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.66
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 1.66
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 1.63
RNA Sequencing of Human iPS derived Cardiomyocytes 1.61
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 1.61
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.56
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 1.55
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 1.53
O-glcnAc reprograms cellular energetics 1.53
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 1.51
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.47
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.46
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.41
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 1.34
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 1.33
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 1.31
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 1.25
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 1.25
miRNAs affected by antagomiR-17 treatment 1.24
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 1.24
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 1.24
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 1.23
RNA expression analysis upon JMJD1C depletion 1.23
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 1.23
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 1.19
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 1.18
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.16
Transcriptome-wide modulation of splicing by the exon junction complex 1.14
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 1.13
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 1.09
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 1.08
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 1.08
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 1.01
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 1.0
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 1.0
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 0.93
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.93
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 0.93
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 0.89
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.88
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 0.88
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 0.88
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 0.81
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.81
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 0.8
HEK293 TFAM Knockout Expression Study 0.79
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 0.76
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 0.73
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 0.73
eRNA: A graphic user interface-based tool for RNA sequencing data analysis 0.72
eRNA: A graphic user interface-based tool for RNA sequencing data analysis [mRNA-Seq] 0.72
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.71
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 0.7
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 0.7
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 0.69
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 0.69
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.67
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.67
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 0.66
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 0.66
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.63
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.63
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.63
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.62
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.62
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.62
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.61
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 0.6
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.59
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.59
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.59
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.54
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.51
Transcriptomic analysis of the role of the integrin a6b4 in detached cells 0.45
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.43
Function and hormonal regulation of GATA3 in human first trimester placentation 0.42
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.42
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes 0.4
Integrative Analysis of Tamoxifen-resistant Cell Line Models Based on Sequencing Genomes, Transcriptomes and Epigenomes [seq] 0.4
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 0.39
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 0.36
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.36
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.34
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 0.33
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 0.33
High-resolution comparative analysis of great ape genomes 0.32
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 0.32
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 0.32
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.3
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.29
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 0.23
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [Toxin] 0.23
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.23
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.23
Myc activation coordinates gene transcription and protein translation responses 0.19
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 0.17
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.17
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.16
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.16
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.14
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.12
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.12
Transcriptional changes in lymphoma cells induced by LSD1 depletion 0.12
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 0.12
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.11
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.08
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.04
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.03
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.02
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.02
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 0.02
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation